anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

All filtered slides

Global slide inventory for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

+Context & problem43,76713.7% · 6,592 docs+Data & charts72,62022.7% · 8,666 docs+Meta & navigation45,93614.4% · 9,739 docs+Recommend & act67,04121.0% · 9,324 docs+Cases & evidence31,2569.8% · 6,067 docs+Frameworks2,1230.7% · 1,232 docs+Appendix35,68211.2% · 6,614 docs+Other21,5496.7% · 5,566 docs

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations
18 30 60

Slide collection

190,921-190,980 of 319,975

filter-aware
42
The diagram is a circular process flow showing the integration of hardware, software, and pharmacy services.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
43
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
44
The slide highlights current reach and future expansion plans into major diagnostics markets.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
45
The slide uses a matrix structure to segment the market and align products/partners to each segment.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
46
Includes a table of use cases and a bar chart of instrument counts.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
47
Uses a before-and-after framing to demonstrate operational efficiency gains.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
48
Uses a three-column process flow to contrast past problems with current solution and future potential.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
49
The slide displays the LumiraDx point-of-care diagnostic platform alongside a row of various test cartridges.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
50
The chart uses a waterfall structure to represent revenue segmentation across different medical diagnostic categories.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
51
The table tracks cumulative instruments, manufacturing capacity, geographic reach, and revenue breakdowns.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
52
LumiraDx | Investor Presentation Deck | 55 slidesLumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
53
The slide displays the LumiraDx platform hardware alongside a row of 10 distinct test cartridges (SARS-CoV-2 variants, HbA1c, D-Dimer, INR, NT-proBNP, CRP).LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
54
The slide uses a two-column layout to contrast Western healthcare policy shifts with global health development initiatives.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
55
This is a transition or filler slide used for branding.LumiraDx | Investor Presentation Deck | 55 slides · LumiraDx
Pitch deck Investor relations 1 hit
01
Slide 1
Includes standard regulatory filing disclaimer regarding confidential treatment.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
02
Includes redacted information regarding rollover requirements and specific counterparty details.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
03
Morgan Stanley | Investment Banking Pitch Book | 13 slidesMorgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
04
The table uses checkmarks for completion and various X marks to denote 'No Interest' or 'Re-confirmed no interest' post a specific filing event.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
05
Includes redacted information regarding specific entities and dates.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
06
Includes volume data and specific event markers leading up to the unaffected date of 9/16/2022.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
07
Market data as of 9/27/2022.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
08
Includes specific callouts for 'Unaffected', 'Violet IOI', 'Violet Revised IOI 1', and 'Orange Counter Proposal 1'.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
09
Morgan Stanley | Investment Banking Pitch Book | 13 slidesMorgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
10
The slide is heavily redacted. It includes a red dashed box highlighting a specific column and a red circle around a cell in that column.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
11
The slide uses a table to compare rollover percentages and amounts across three scenarios for various investors.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
12
Includes a sensitivity table for sponsor equity based on rollover percentage and purchase price, and a pro forma balance sheet adjustment table.Morgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
13
Morgan Stanley | Investment Banking Pitch Book | 13 slidesMorgan Stanley | Investment Banking Pitch Book | 13 slides · Morgan Stanley
Regulatory filing Investment bank 1 hit
01
Slide 1
Includes standard confidential treatment disclosure and exhibit reference.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Situation & Context1 hit
02
Morgan Stanley | Investment Banking Pitch Book | 30 slidesMorgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Situation & Context1 hit
03
The table uses checkmarks for completed steps and X marks (yellow/red) to indicate lack of engagement or interest.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Situation & Context1 hit
04
The slide uses a calendar grid to track project milestones and management availability.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Situation & Context1 hit
05
The chart shows Orange outperforming the selected peer groups and the S&P 500 index over the specified period.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Benchmark Gap1 hit
06
Includes annotations for specific dates and events impacting stock price.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Benchmark Gap1 hit
07
Includes valuation ranges for Street Case and Management Case scenarios, with a reference line at $19.41.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Benchmark Gap1 hit
08
Includes management estimates vs street consensus for Orange, compared against two peer groups.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Problem & ComplicationLoop · Benchmark Gap1 hit
09
Includes sensitivity analysis on NTM multiples and discount factors.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
10
Includes detailed valuation inputs and sensitivity tables for share price based on varying multiples and discount factors.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
11
Includes a dashed box highlighting management-approved extrapolations and a circle highlighting the 29% uFCF margin in CY31E.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
12
Includes sensitivity tables for Share Price, Implied Exit Multiples, and Revenue/FCF. Data is presented in $MM.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
13
Includes a specific callout for 'Orange' at 8.8x multiple.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
14
Transaction data as of September 2022; excludes withdrawn deals and those by strategic acquirers.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Hypothesis Test1 hit
15
Includes deal size, date, consideration type, activist involvement, premium, NTM growth, LFCF margin, Rule of 40, and revenue multiples.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
16
The slide contains redacted text blocks. The structure suggests a hierarchical list of procedural steps.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
17
The slide uses a bulleted list structure to organize communication steps, with redactions obscuring specific details.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
18
The slide uses a grid structure to compare items, with a red dashed box highlighting a specific section of the table and a blue shaded area emphasizing specific rows.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
19
The slide uses a two-column layout to distinguish between 'Sponsors' and 'Strategics', with tiered sub-categories for each.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank Beat · Impact & Next Steps1 hit
20
Morgan Stanley | Investment Banking Pitch Book | 30 slidesMorgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
21
Project Orange, Preliminary and Confidential Draft, Page 21.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
22
Includes historical actuals (2019-2021) and projections (2022-2025).Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
23
The slide combines a financial table (capitalization) with a time-series chart (price/volume) and event annotations.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
24
The slide uses line charts to track valuation trends. Data points represent specific valuation multiples at the end of the period.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
25
Includes a summary table of average multiples across different economic periods.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
26
Data as of 9/12/2022. Rule of 40 defined as sum of revenue growth and free cash flow margin.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
27
Includes annotations highlighting changes in price targets and revenue estimates following Q2'22 earnings.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
28
The slide presents a standard WACC build-up model with sensitivity adjustments.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
29
Standard treasury stock method calculation for diluted shares and enterprise value.Morgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
30
Morgan Stanley | Investment Banking Pitch Book | 30 slidesMorgan Stanley | Investment Banking Pitch Book | 30 slides · Morgan Stanley
Consulting deck Investment bank 1 hit
01
Slide 1
Includes standard Morgan Stanley confidential treatment disclosure.Morgan Stanley | Investment Banking Pitch Book | 8 slides · Morgan Stanley
Consulting deck Investment bank Beat · Situation & ContextLoop · Cost Of Inaction1 hit
02
Confidential document from Morgan Stanley. Contains illustrative examples only.Morgan Stanley | Investment Banking Pitch Book | 8 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit
03
Includes detailed footnotes regarding data sources, management case assumptions, and rollover calculations.Morgan Stanley | Investment Banking Pitch Book | 8 slides · Morgan Stanley
Consulting deck Investment bank Beat · Evidence & ProofLoop · Pattern Hunter1 hit